Dipyridamole (NCS HealthCare of KY, Inc dba Vangard Labs)
Welcome to the PulseAid listing for the Dipyridamole drug offered from NCS HealthCare of KY, Inc dba Vangard Labs. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | NCS HealthCare of KY, Inc dba Vangard Labs |
NON-PROPRIETARY NAME: | Dipyridamole |
SUBSTANCE NAME: | DIPYRIDAMOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2011-01-23 |
END MARKETING DATE: | 0000-00-00 |
Dipyridamole HUMAN PRESCRIPTION DRUG Details:
Item Description | Dipyridamole from NCS HealthCare of KY, Inc dba Vangard Labs |
LABELER NAME: | NCS HealthCare of KY, Inc dba Vangard Labs |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2011-01-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0615-1573_f26e686a-aa0a-4e50-a492-d25a3fe8c201 |
PRODUCT NDC: | 0615-1573 |
APPLICATION NUMBER: | ANDA087716 |
Other DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers: